Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Zeria Pharmaceutical had annual revenue of 89.16B JPY with 2.12% growth. Zeria Pharmaceutical had revenue of 25.08B in the quarter ending March 31, 2026, with 11.29% growth.

• Revenue: 89.16B
• Revenue Growth: +2.12%
• P/S Ratio: 1.13
• Revenue / Employee: 51.06M
• Employees: 1,746
• Market Cap: 101.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	89.16B	1.85B	2.12%
Mar 31, 2025	87.31B	11.59B	15.30%
Mar 31, 2024	75.73B	7.34B	10.74%
Mar 31, 2023	68.38B	8.85B	14.87%
Mar 31, 2022	59.53B	4.09B	7.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error